Area of research
Genetics · Infectious Diseases
Research interest
Research interests include Inflammatory Bowel Disease, Clostridium difficile and Clostridium perfringens research, Microscopic Colitis, and Gut microbiota and health.
Oral rehydration solution for the management of fluid and electrolyte disturbances in patients with an ileostomy: A scoping review.
Gastrointestinal Symptom Burden After Total Pancreatectomy With Islet Autotransplantation: A Prospective Observational Cohort Study.
Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIV
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights.
Novel Microbial Engraftment Trajectories Following Microbiota Transplant Therapy in Ulcerative Colitis.
Nutritional optimization of fecal microbiota transplantation in humans: a scoping review.
Diagnosis and Management of Clostridioides difficile in Inflammatory Bowel Disease.
Metagenomic source tracking after microbiota transplant therapy.
Risk Factors for Antibiotic Exposure Post-Fecal Microbiota Transplantation for Recurrent <i>Clostridioides difficile</i> Infection: A Prospective Multicenter Observational Study.
AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases
AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn’s Disease
Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus.
Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn's Disease.
Impact of the Reverse 2-Step Algorithm for <i>Clostridioides difficile</i> Testing in the Microbiology Laboratory on Hospitalized Patients.
Rethinking Faecal Microbiota Transplant for Pouchitis.
Mycophenolate Mofetil-Induced Pneumatosis Intestinalis.
Diagnosis and management of <i>de novo</i> inflammatory bowel disease after solid organ transplantation in the era of biologic therapy: a case series.
Contribution of Common Sulfur-Containing Substrates to Hydrogen Sulfide Production By Human Gut Microbiota Using an <i>In Vitro</i> Model Standardized For Bacterial Counts.
Simulated cost-effectiveness of a novel precision-guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy.
A Short-Term Enteral Nutrition Protocol for Management of Adult Crohn's Disease-A Pilot Trial.
Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
Diagnosis of Eosinophilic Esophagitis at the Time of Esophageal Food Impaction.
Kidney Biopsy Findings and Clinical Outcomes of US Veterans with Inflammatory Bowel Disease.
Multicenter Study of Nonadherence to Self-Injectable Biologic Therapy in Patients With Inflammatory Bowel Disease: Risk Factors and Outcomes.
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection.